Abstract
One in every 12 women will develop breast cancer; the incidence increases with age, dietary fat intake, caloric intake, height, and weight. The 10-year survival rate of breast cancer patients who refuse therapy is virtually zero. Segmental mastectomy plus radiation and lumpectomy, combined with systemic (adjuvant) chemotherapy, are alternatives under investigation at the National Institute of Health that may increase the survival rate by decreasing metastatic complications.
| Original language | English |
|---|---|
| Pages (from-to) | 97-99 |
| Number of pages | 3 |
| Journal | Public Health Reports |
| Volume | 102 |
| Issue number | 4 SUPPL. JULY/AUG. |
| State | Published - Dec 1 1987 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
Cite this
Women' health : Cancer. Women and breast cancer. / Lippman, Marc E.
In: Public Health Reports, Vol. 102, No. 4 SUPPL. JULY/AUG., 01.12.1987, p. 97-99.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Women' health
T2 - Cancer. Women and breast cancer
AU - Lippman, Marc E
PY - 1987/12/1
Y1 - 1987/12/1
N2 - One in every 12 women will develop breast cancer; the incidence increases with age, dietary fat intake, caloric intake, height, and weight. The 10-year survival rate of breast cancer patients who refuse therapy is virtually zero. Segmental mastectomy plus radiation and lumpectomy, combined with systemic (adjuvant) chemotherapy, are alternatives under investigation at the National Institute of Health that may increase the survival rate by decreasing metastatic complications.
AB - One in every 12 women will develop breast cancer; the incidence increases with age, dietary fat intake, caloric intake, height, and weight. The 10-year survival rate of breast cancer patients who refuse therapy is virtually zero. Segmental mastectomy plus radiation and lumpectomy, combined with systemic (adjuvant) chemotherapy, are alternatives under investigation at the National Institute of Health that may increase the survival rate by decreasing metastatic complications.
UR - http://www.scopus.com/inward/record.url?scp=0023641218&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023641218&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0023641218
VL - 102
SP - 97
EP - 99
JO - Public Health Reports
JF - Public Health Reports
SN - 0033-3549
IS - 4 SUPPL. JULY/AUG.
ER -